首页> 外国专利> NEW PHARMACEUTICAL SOLID FORMS (1S, 2S, 3R, 5S) -3- 7 - (1R, 2S) -2- (3,4-DIFTORFENIL) CYCLOPROPYLAMINO -5- (PROPYLTIO) -3H- 1,2 , 3 TRIAZOLO 4,5-d PYRIMIDIN-3-IL -5- (2-HYDROXYETHOXY) CYCLOPENTAN-1,2-DIOLA

NEW PHARMACEUTICAL SOLID FORMS (1S, 2S, 3R, 5S) -3- 7 - (1R, 2S) -2- (3,4-DIFTORFENIL) CYCLOPROPYLAMINO -5- (PROPYLTIO) -3H- 1,2 , 3 TRIAZOLO 4,5-d PYRIMIDIN-3-IL -5- (2-HYDROXYETHOXY) CYCLOPENTAN-1,2-DIOLA

机译:新的药物固体形式(1S,2S,3R,5S)-3- [7-[(1R,2S)-2-(3,4-二氟甲腈)环丙酰胺基] -5-(丙炔基)-3H- [1,2 ,3] TRIAZOLO [4,5-d] PYRIMIDIN-3-IL] -5-(2-羟基乙氧基)环戊烷-1,2-二醇

摘要

Solid State Structures (1S, 2S, 3R, 5S) -3- [7 - [(1R, 2S) -2- (3,4-difluorophenyl) cyclopropyl] -5- (propylthio) -3H- [1,2,3 ] triazolo [4,5-d] pyrimidin-3-yl] -5- (2-hydroxyethoxy) cyclopentane-1,2-diol (hereinafter referred to as ticagrelor) as a stable co-crystalline form of 3-hydroxy-2-naphthoic acids, as well as the solvate of 1,4-dioxane and methods for their preparation.
机译:固态结构(1S,2S,3R,5S)-3- [7-[(1R,2S)-2-(3,4-二氟苯基)环丙基] -5-(丙硫基)-3H- [1,2, 3]三唑并[4,5-d]嘧啶-3-基] -5-(2-羟基乙氧基)环戊烷-1,2-二醇(以下称为替卡格雷),为3-羟基-的稳定共晶形式。 2-萘甲酸以及1,4-二恶烷的溶剂化物及其制备方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号